CD274 and neoplasm: Since tumor cells and PD-L1-expressing tumor-associated immune cells can be observed in a variety of tumor microenvironments,37,51,52 the current dual-targeting CAR design may provide a broad solution for CAR-T cell therapy strategies in solid tumors.